Organoids and Spheroids Market Size Worth $2.47 Billion by 2028 | CAGR: 22.8%

Organoids and Spheroids Market Size Worth $2.47 Billion by 2028 | CAGR: 22.8%

The global organoids and spheroids market is expected to reach USD 2.47 billion by 2028 according to a new study by Polaris Market Research. The report “Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report, By Type (Organoids, Spheroids); By Application (Developmental Biology, Personalized Medicine, Regenerative Medicine, Disease Pathology Studies, Drug Toxicity & Efficacy Testing); By End-Use; By Regions; Segment Forecast, 2021 - 2028 gives a detailed insight into current market dynamics and provides analysis on future market growth.


The global organoids and spheroids industry is anticipated to grow, owing to the growing incidence of cancer, innovations in the tissue culture system, and continually failing organ transplantation surgeries. The compatibility between the donor and recipient should be cross-checked through artificial cell culture systems to save time and money.


The global market industry is fragmented based on type, application, end-use, and region. In terms of type, the market is segmented into organoids and spheroids. The application segment is further divided into developmental biology, personalized medicine, regenerative medicine, disease pathology studies, and drug toxicity & efficacy testing. In terms of end-use, the market is segmented into biotechnology and pharmaceutical industries, academic & research institutes, and hospitals and diagnostic centers.


Have Questions? Request a sample or make an Inquiry before buying this report by clicking the following link:


Segment Highlights

  • The spheroids market segment accounted for a major revenue share owing to its applicability in cancer research. The segment held over 50.0% of the global share in 2020. However, the organoid segment is expected to witness highest CAGR during the forecast period.

  • Based on application, the development biology segment is projected to constitute almost half of the market in 2028. This is can be attributed for increased use of cell culture systems in the developmental biology.

  • North America region is dominating the global organoids and spheroids industry, holding over one-third of the market share throughout the forecast period. The presence of key companies and increasing funding towards research are the factors responsible for its growth

List of Key Players

  • 3D BioMatrix
  • 3D Biotek LLC
  • AMS Biotechnology (Europe) Limited
  • Cellesce Ltd.
  • Corning Incorporated
  • Greiner Bio-One
  • Hubrecht Organoid Technology (HUB)
  • InSphero/Perkin Elmer
  • Prellis Biologics
  • Others


Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end-use, and region

Organoids and Spheroids, Type Outlook (Revenue - USD Million, 2016 - 2028)

  • By Type
    • Organoids
      • By Type
        • Neural
        • Hepatic
        • Intestinal
        • Other
      • By Method
        • General Submerged Method for Organoid Culture
        • Crypt Organoid Culture Techniques
        • Air Liquid Interface (ALI) Method for Organoid Culture
        • Clonal Organoids from Lgr5+ Cells
        • Brain and Retina Organoid Formation Protocol
      • By Source
        • Primary Tissues
        • Stem Cells
    • Spheroids
      • By Type
        • Multicellular tumor spheroids (MCTS)
        • Neurospheres
        • Mammospheres
        • Hepatospheres
        • Embryoid bodies
      • By Method
        • Micropatterned Plates
        • Low Cell Attachment Plates
        • Hanging Drop Method
        • Others
      • By Source
        • Cell Line
        • Primary Cell
        • iPSCs Derived Cells

Organoids and Spheroids, Application Outlook (Revenue - USD Million, 2016 - 2028)

  • Developmental Biology
  • Personalized Medicine
  • Regenerative Medicine
  • Disease Pathology Studies
  • Drug Toxicity & Efficacy Testing

Organoids and Spheroids, End-Use Outlook (Revenue - USD Million, 2016 - 2028)

  • Biotechnology & Pharmaceutical Industries
  • Academic & Research Institutes
  • Hospitals & Diagnostic Centers

Organoids and Spheroids, Regional Outlook (Revenue - USD Million, 2016 - 2028)

  • North America
    • U.S.
    • Canada
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
    • Netherlands
    • Austria
  • Asia Pacific
    • China
    • India
    • Japan
    • Malaysia
    • South Korea
    • Indonesia
  • Central & South America
    • Mexico
    • Brazil
    • Argentina
  • Middle East & Africa
    • UAE
    • Saudi Arabia
    • Israel
    • South Africa